welcome!
New to Close Concerns?
Subscribe
Already registered?
Log in
WHAT WE DO
consulting
strategic advice and comprehensive information for those interested in the diabetes industry
diabetes close up
our monthly newsletter
industry reports
periodically we take the long view on trends or on specific breakthroughs.
TEAM
Interview with Dr. Zach Bloomgarden
I sat down recently with Dr. Zach Bloomgarden, who is noted not only for his huge clinical practice (more than 1,000 patients) on New York's Upper East Side but also for his many articles on diabetes (nearly 250). Since 1994, he has also written over 150 columns, "Perspectives on the News" for Diabetes Care. Dr. Bloomgarden studied mathematics at Princeton University and received his medical degree from Albert Einstein College of Medicine, followed by postdoctoral training at Montefiore Hospital in the Bronx and a fellowship at Vanderbilt University Hospital in Nashville, Tenn. He is currently a Clinical Professor of Medicine at Mount Sinai School of Medicine. Dr. Bloomgarden is a reviewer for Diabetes Care, Mayo Clinic Proceedings, the Archives of Internal Medicine, Practical Diabetology, Diabetes Management and Health Outcomes, Journal of Clinical Endocrinology and Metabolism, and Metabolism. He also advises managed care companies on diabetes as well as manufacturers, and has served as a Principle Investigator in dozens of clinical trials. He is a founding member of the Metropolitan Diabetes Society of New York and his personal research interests include insulin resistance and diabetes technology. He spoke to us about the latest controversy with Galvus, the importance of rimonabant, the potential of continuous glucose monitoring, and much more.